Pharma Pulse 5/9/24: 7 Everyday Work Problems AI Helps Solve, Positive Outcomes of Rituximab Use in Multiple Sclerosis & more

LogiPharma Europe 2024: Tower Cold Chain Global Head of Product Development Discusses the Future of Cell & Gene Therapy and Cold Chain Storage

In an interview with Pharma Commerce Editor Nicholas Saraceno, Martin Hawes, Global Head of Product Development, Tower Cold Chain offers insights on the future of cell & gene therapies when it comes to cold chain storage.

Most Real-World Studies Report Positive Outcomes of Rituximab Use in Multiple Sclerosis

Although several clinical trials have confirmed the safety and efficacy of rituximab in oncology and autoimmune disease, and even as off-label use in MS, real-world evidence is still necessary to help guide clinicians and managed care professionals in their treatment and coverage decision-making.

7 Everyday Work Problems AI Helps Me Solve

It’s hard to get your head around all the things artificial intelligence will do, someday. So instead focus on how it can make your life better right now.

Cencora To Host Inaugural ThinkLive Cell and Gene Therapy Summit

Two-day event will convene industry leaders to explore strategies to overcome challenges across the product lifecycle — from R&D to global commercialization.

Karla Jo Helms on LinkedIn:

Wow the integration of this tool it's going to open up some amazing possibilities Kalim! Excited about the implications to the industry.

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs